{"id":8948,"date":"2016-04-11T08:12:00","date_gmt":"2016-04-11T16:12:00","guid":{"rendered":"http:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-new-drug-for-chronic-lymphocytic-leukemia-in-patients-with-a-specific-chromosomal-abnormality\/"},"modified":"2016-04-11T08:12:00","modified_gmt":"2016-04-11T16:12:00","slug":"fda-approves-new-drug-for-chronic-lymphocytic-leukemia-in-patients-with-a-specific-chromosomal-abnormality","status":"publish","type":"post","link":"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-new-drug-for-chronic-lymphocytic-leukemia-in-patients-with-a-specific-chromosomal-abnormality\/","title":{"rendered":"FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality"},"content":{"rendered":"<p>The U.S. Food and Drug Administration today approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p deletion and who have been treated with a least one prior therapy. Venclexta is the first FDA-approved treatment that targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with CLL.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration today approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p deletion and who have been treated with a least one prior therapy. Venclexta is the first FDA-approved treatment that targets the B-cell lymphoma 2 (BCL-2) protein, which supports &hellip; <a href=\"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-new-drug-for-chronic-lymphocytic-leukemia-in-patients-with-a-specific-chromosomal-abnormality\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"1","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,4,3,6],"tags":[],"class_list":["post-8948","post","type-post","status-publish","format-standard","hentry","category-drug-reacalls-safety-notices-information","category-drug-safety-information-podcasts","category-food-drug-recalls","category-food-safety-news"],"_links":{"self":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/8948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/comments?post=8948"}],"version-history":[{"count":0,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/8948\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/media?parent=8948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/categories?post=8948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/tags?post=8948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}